Wealthstreet Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Wealthstreet Investment Advisors's GILD Position: Q2 2021 in Review
Wealthstreet Investment Advisors sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 18,795 shares — an estimated $1.22M sold.
Wealthstreet Investment Advisors first reported a position in GILD in Q4 2017 and held it in 14 quarters. The position peaked at $5.15M in Q4 2017. 1,546 funds tracked by Wall St. Rank hold GILD as of Q2 2021.
- Wealthstreet Investment Advisors reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
- Wealthstreet Investment Advisors sold 18,795 Gilead Sciences shares in Q2 2021, an estimated $1.22M.
- Wealthstreet Investment Advisors first reported a position in Gilead Sciences in Q4 2017 and held it in 14 quarters.
- Wealthstreet Investment Advisors's Gilead Sciences position peaked at $5.15M in Q4 2017.
- 1,546 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.
Based on Wealthstreet Investment Advisors's 13F filing for Q2 2021, filed 2 Aug 2021.